Differences in health policies for drug availability in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension across Latin America
Digital
- Autores:
-
Orozco‐Levi, Mauricio
Caneva, Jorge
Fernandes, Caio
Restrepo‐Jaramillo, Ricardo
Zayas, Nayeli
Conde, Rafael
Diez, Mirta
Jardim, Carlos
Pacheco-Gallego, Manuel C.
Melatini, Luciano
Valdez, Héctor
Pulido, Tomas
- Tipo de recurso:
- Article of journal
- Fecha de publicación:
- 2022
- Institución:
- Universidad de Santander
- Repositorio:
- Repositorio Universidad de Santander
- Idioma:
- eng
- OAI Identifier:
- oai:repositorio.udes.edu.co:001/7371
- Palabra clave:
- Drug combinations
Hypertension
Pulmonary
Risk assessment
- Rights
- openAccess
- License
- Atribución-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0)
id |
RUDES2_5460879c10681a498e9c1024cb3347c0 |
---|---|
oai_identifier_str |
oai:repositorio.udes.edu.co:001/7371 |
network_acronym_str |
RUDES2 |
network_name_str |
Repositorio Universidad de Santander |
repository_id_str |
|
dc.title.spa.fl_str_mv |
Differences in health policies for drug availability in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension across Latin America |
title |
Differences in health policies for drug availability in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension across Latin America |
spellingShingle |
Differences in health policies for drug availability in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension across Latin America Drug combinations Hypertension Pulmonary Risk assessment |
title_short |
Differences in health policies for drug availability in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension across Latin America |
title_full |
Differences in health policies for drug availability in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension across Latin America |
title_fullStr |
Differences in health policies for drug availability in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension across Latin America |
title_full_unstemmed |
Differences in health policies for drug availability in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension across Latin America |
title_sort |
Differences in health policies for drug availability in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension across Latin America |
dc.creator.fl_str_mv |
Orozco‐Levi, Mauricio Caneva, Jorge Fernandes, Caio Restrepo‐Jaramillo, Ricardo Zayas, Nayeli Conde, Rafael Diez, Mirta Jardim, Carlos Pacheco-Gallego, Manuel C. Melatini, Luciano Valdez, Héctor Pulido, Tomas |
dc.contributor.author.none.fl_str_mv |
Orozco‐Levi, Mauricio Caneva, Jorge Fernandes, Caio Restrepo‐Jaramillo, Ricardo Zayas, Nayeli Conde, Rafael Diez, Mirta Jardim, Carlos Pacheco-Gallego, Manuel C. Melatini, Luciano Valdez, Héctor Pulido, Tomas |
dc.contributor.researchgroup.spa.fl_str_mv |
Masira |
dc.subject.proposal.eng.fl_str_mv |
Drug combinations Hypertension Pulmonary Risk assessment |
topic |
Drug combinations Hypertension Pulmonary Risk assessment |
description |
Digital |
publishDate |
2022 |
dc.date.accessioned.none.fl_str_mv |
2022-08-09T22:15:45Z |
dc.date.available.none.fl_str_mv |
2022-08-09T22:15:45Z |
dc.date.issued.none.fl_str_mv |
2022-01-05 |
dc.type.spa.fl_str_mv |
Artículo de revista |
dc.type.coar.fl_str_mv |
http://purl.org/coar/resource_type/c_2df8fbb1 |
dc.type.coarversion.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
dc.type.coar.spa.fl_str_mv |
http://purl.org/coar/resource_type/c_6501 |
dc.type.content.spa.fl_str_mv |
Text |
dc.type.driver.spa.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.redcol.spa.fl_str_mv |
http://purl.org/redcol/resource_type/ART |
dc.type.version.spa.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
http://purl.org/coar/resource_type/c_6501 |
status_str |
publishedVersion |
dc.identifier.doi.none.fl_str_mv |
https://doi.org/10.1002/pul2.12012 |
dc.identifier.eissn.spa.fl_str_mv |
2045-8940 |
dc.identifier.issn.spa.fl_str_mv |
2045-8940 |
dc.identifier.uri.none.fl_str_mv |
https://repositorio.udes.edu.co/handle/001/7371 |
url |
https://doi.org/10.1002/pul2.12012 https://repositorio.udes.edu.co/handle/001/7371 |
identifier_str_mv |
2045-8940 |
dc.language.iso.spa.fl_str_mv |
eng |
language |
eng |
dc.relation.citationvolume.spa.fl_str_mv |
12 |
dc.relation.cites.none.fl_str_mv |
Orozco‐Levi M, CánevaJ, Fernandes C, Restrepo‐Jaramillo R, Zayas N,Conde R, Diez M, Jardim C, Pacheco Gallego MC,Melatini L, Valdéz H, Pulido T. Differences inhealth policies for drug availability in pulmonaryarterial hypertension and chronic thromboembolicpulmonary hypertension across Latin America.Pulm Circ. 2022;12:e12012. https://doi.org/10.1002/pul2.12012 |
dc.relation.indexed.spa.fl_str_mv |
Scopus |
dc.relation.ispartofjournal.spa.fl_str_mv |
Pulmonary Circulation |
dc.rights.coar.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 |
dc.rights.accessrights.spa.fl_str_mv |
info:eu-repo/semantics/openAccess |
dc.rights.creativecommons.spa.fl_str_mv |
Atribución-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0) |
dc.rights.uri.spa.fl_str_mv |
https://creativecommons.org/licenses/by-nc-nd/4.0/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
Atribución-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0) https://creativecommons.org/licenses/by-nc-nd/4.0/ http://purl.org/coar/access_right/c_abf2 |
dc.format.extent.spa.fl_str_mv |
10 p |
dc.format.mimetype.spa.fl_str_mv |
application/pdf |
dc.publisher.place.spa.fl_str_mv |
USA |
dc.source.spa.fl_str_mv |
https://onlinelibrary.wiley.com/doi/epdf/10.1002/pul2.12012 |
institution |
Universidad de Santander |
bitstream.url.fl_str_mv |
https://repositorio.udes.edu.co/bitstreams/6b9d154a-c42c-4cec-a2bc-dbf8841f635c/download https://repositorio.udes.edu.co/bitstreams/ae1f0478-5f32-4e33-b80a-d0ca95ac45ac/download https://repositorio.udes.edu.co/bitstreams/c61b40f9-c9a2-49f3-9761-31826feefcb0/download https://repositorio.udes.edu.co/bitstreams/3796b55b-f714-43c3-85b0-2b6271e4b7fc/download |
bitstream.checksum.fl_str_mv |
443a211d2b890747c80e41dc785d7ea6 38d94cf55aa1bf2dac1a736ac45c881c 5dbe86c1111d64f45ba435df98fdc825 494ddcaff69215b1869cb12a6bfd921c |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositorio Universidad de Santander |
repository.mail.fl_str_mv |
soporte@metabiblioteca.com |
_version_ |
1814158592260964352 |
spelling |
Orozco‐Levi, Mauricio35bb5891-51e0-49c0-90fa-c8623d7a476b-1Caneva, Jorgeee80c39e-3d33-467c-9e87-cc82410a0f95-1Fernandes, Caio82c118de-af11-4b89-a65b-5353e06d9740-1Restrepo‐Jaramillo, Ricardo1d4238cc-3245-4897-bf62-63534549938e-1Zayas, Nayelia8fc8c4e-e6ac-474d-984a-9ce95dd603cd-1Conde, Rafael13d4d289-c8c6-41cb-a2e0-1967cc0cf5f0-1Diez, Mirta811bcada-e1e6-4246-9f0c-34d5c0a73af4-1Jardim, Carlosbe54a736-2c8a-4657-a3ff-58a96d29fcec-1Pacheco-Gallego, Manuel C.e3d6aba3-a9c2-4ab1-9e39-d5c22991a00a-1Melatini, Lucianodebdef43-ca64-483f-bca8-77f17b5acaa7-1Valdez, Héctor270db9f0-f598-4221-9c75-1234036e0c47-1Pulido, Tomas4e854622-e5e2-4f07-bb01-b2fe13563dce-1Masira2022-08-09T22:15:45Z2022-08-09T22:15:45Z2022-01-05DigitalTreatment for pulmonary arterial hypertension and chronic thromboembolicpulmonary hypertension in Latin America differs between countries, withregard to disease etiology, health insurance coverage, and drug availability. Agroup of experts from Latin America, met to share regional experiences andpropose possible lines of collaboration. The available evidence, regional clin-ical practice data, and the global context of the proceedings of the 6th WorldSymposium on Pulmonary Hypertension, held in Nice, France, in February2018, were analyzed. Here, we discuss some priority concepts identified that could guide transnational interaction and research strategies in Latin Amer-ica: (1) despite being evidence‐based, the 6th World Symposium on PulmonaryHypertension proceedings may not be applicable in Latin American countries;(2) proactive identification and diagnosis of patients in Latin America isneeded; (3) education of physicians and standardization of appropriate treat-ment for pulmonary arterial hypertension and chronic thromboembolic pul-monary hypertension is vital; (4) our clinical experience for the treatmentstrategy for pulmonary arterial hypertension and chronic thromboembolicpulmonary hypertension is based on drug availability in Argentina, Brazil,Colombia and México; (5) there are difficulties inherent to the consultation ofpatients with pulmonary arterial hypertension and chronic thromboembolicpulmonary hypertension, and access to treatment; (6) the importance of datageneration and research of Latin American‐specific issues related to pul-monary arterial hypertension and chronic thromboembolic pulmonary hy-pertension is highlighted.Ciencias Médicas y de la Salud10 papplication/pdfhttps://doi.org/10.1002/pul2.120122045-89402045-8940https://repositorio.udes.edu.co/handle/001/7371engUSA12Orozco‐Levi M, CánevaJ, Fernandes C, Restrepo‐Jaramillo R, Zayas N,Conde R, Diez M, Jardim C, Pacheco Gallego MC,Melatini L, Valdéz H, Pulido T. Differences inhealth policies for drug availability in pulmonaryarterial hypertension and chronic thromboembolicpulmonary hypertension across Latin America.Pulm Circ. 2022;12:e12012. https://doi.org/10.1002/pul2.12012ScopusPulmonary Circulation© 2021 The Authors.Pulmonary Circulationpublished by John Wiley & Sons Ltd on behalf of Pulmonary Vascular Research Institute.info:eu-repo/semantics/openAccessAtribución-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0)https://creativecommons.org/licenses/by-nc-nd/4.0/http://purl.org/coar/access_right/c_abf2https://onlinelibrary.wiley.com/doi/epdf/10.1002/pul2.12012Drug combinationsHypertensionPulmonaryRisk assessmentDifferences in health policies for drug availability in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension across Latin AmericaArtículo de revistahttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1Textinfo:eu-repo/semantics/articlehttp://purl.org/redcol/resource_type/ARTinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/version/c_970fb48d4fbd8a85Todas las AudienciasPublicationORIGINALDifferences in health policies for drug availability in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension across Latin America.pdfDifferences in health policies for drug availability in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension across Latin America.pdfapplication/pdf223067https://repositorio.udes.edu.co/bitstreams/6b9d154a-c42c-4cec-a2bc-dbf8841f635c/download443a211d2b890747c80e41dc785d7ea6MD51LICENSElicense.txtlicense.txttext/plain; charset=utf-859https://repositorio.udes.edu.co/bitstreams/ae1f0478-5f32-4e33-b80a-d0ca95ac45ac/download38d94cf55aa1bf2dac1a736ac45c881cMD52TEXTDifferences in health policies for drug availability in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension across Latin America.pdf.txtDifferences in health policies for drug availability in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension across Latin America.pdf.txtExtracted texttext/plain5https://repositorio.udes.edu.co/bitstreams/c61b40f9-c9a2-49f3-9761-31826feefcb0/download5dbe86c1111d64f45ba435df98fdc825MD53THUMBNAILDifferences in health policies for drug availability in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension across Latin America.pdf.jpgDifferences in health policies for drug availability in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension across Latin America.pdf.jpgGenerated Thumbnailimage/jpeg12478https://repositorio.udes.edu.co/bitstreams/3796b55b-f714-43c3-85b0-2b6271e4b7fc/download494ddcaff69215b1869cb12a6bfd921cMD54001/7371oai:repositorio.udes.edu.co:001/73712023-10-09 18:03:19.809https://creativecommons.org/licenses/by-nc-nd/4.0/© 2021 The Authors.Pulmonary Circulationpublished by John Wiley & Sons Ltd on behalf of Pulmonary Vascular Research Institute.https://repositorio.udes.edu.coRepositorio Universidad de Santandersoporte@metabiblioteca.comTGljZW5jaWEgZGUgUHVibGljYWNpw7NuIFVERVMKRGlyZWN0cmljZXMgZGUgVVNPIHkgQUNDRVNPCgo= |